ANN ARBOR, Mich. (7/8/2008)-NanoBio® Corp., a biopharmaceutical company focused on developing and commercializing novel products to prevent and treat infectious diseases, today announced the appointment of Dr. Daniel B. Dubin to its board of directors.

Dr. Dubin currently serves as Vice Chairman and a Director at Leerink Swann, a leading healthcare and biotechnology investment banking firm.

“Dan’s keen understanding of the life sciences investment banking field and his clinical experience as a dermatologist bring a dual perspective

Continue reading: Daniel B. Dubin, MD Joins NanoBio Corp.’s Board of Directors